Idarucizumab
ATC V03AB37 · 11 markets · 12 records
AU 2 records · 2 strengths
- 2,500 mginjectionPRAXBIND idarucizumab (rch) 50 mg/ml solution for injection/infusion vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 strengths
- 50 mginjectionPraxbind
GB 1 records · 1 strengths
- 2,500 mg/50 mLinjectionPraxbind 2.5g/50ml solution for infusion vials
CA 1 records · 1 strengths
- 50 mgliquidPraxbind
SG 1 records · 1 strengths
- 50 mg/mLinjectionPRAXBIND SOLUTION FOR INJECTION/INFUSION 50 MG/ML
ES 1 records · 1 strengths
- 50 mg/1 mLinjectionPraxbind
TW 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 50 mg/1 mLinjectionPRAXBIND 2,5 g/50 ml, solution injectable/pour perfusion
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.